Cargando…

RBBP6 induces non-small cell lung cancer cell proliferation and high expression is associated with poor prognosis

Lung cancer is the most common cause of cancer-associated mortality in China with 85% of patients having non-small cell lung cancer (NSCLC). Identifying NSCLC driver genes and prognostic markers is critical to reducing these numbers. The studies of retinoblastoma binding protein 6 (RBBP6) performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiu-Shi, Wei, Shi-Rong, Xiao, Hua-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068609/ https://www.ncbi.nlm.nih.gov/pubmed/32218844 http://dx.doi.org/10.3892/ol.2020.11403

Ejemplares similares

Prognosis value of RBBP8 expression in plasma cell myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer
por: Chen, Jian, et al.
Publicado: (2013)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

Circ_0110498 facilitates the cisplatin resistance of non‐small cell lung cancer by mediating the miR‐1287‐5p/RBBP4 axis
por: Hao, Dexun, et al.
Publicado: (2023)

RBBP6 expressional effects on cell proliferation and apoptosis in breast cancer cell lines with distinct p53 statuses
por: Motadi, Lesetja Raymond, et al.
Publicado: (2018)

High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis
por: Nathalie, Heuzé-Vourc’h, et al.
Publicado: (2009)

Investigating the Effects of RBBP6 Gene Expression on Telomerase Activity in Cervical Cancer Cells
por: Mosweu, Mpho, et al.
Publicado: (2020)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis
por: Wang, Zhao, et al.
Publicado: (2019)

Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer
por: Wang, Qiang, et al.
Publicado: (2015)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression
por: Sun, Yue, et al.
Publicado: (2017)

SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Li, Jing, et al.
Publicado: (2020)

RBBP4 Enhances Platinum Chemo Resistance in Lung Adenocarcinoma
por: Wang, Nianwu, et al.
Publicado: (2021)

Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

The C. elegans Homolog of RBBP6 (RBPL-1) Regulates Fertility through Controlling Cell Proliferation in the Germline and Nutrient Synthesis in the Intestine
por: Huang, Ping, et al.
Publicado: (2013)

Rbbp4 Suppresses Premature Differentiation of Embryonic Stem Cells
por: Huang, Yikai, et al.
Publicado: (2021)

EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer
por: Lu, Xiyi, et al.
Publicado: (2018)

RBBP6: a potential biomarker of apoptosis induction in human cervical cancer cell lines
por: Moela, Pontsho, et al.
Publicado: (2016)

GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
por: Zeng, Jing, et al.
Publicado: (2014)

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer
por: Ma, Weijie, et al.
Publicado: (2023)

Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer
por: Kong, Peng-Zhou, et al.
Publicado: (2016)

Cell cycle‐related and expression‐elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non‐small‐cell lung cancer
por: Li, Weimiao, et al.
Publicado: (2018)

High developmental pluripotency-associated 4 expression promotes cell proliferation and glycolysis, and predicts poor prognosis in non-small-cell lung cancer
por: Li, Longfei, et al.
Publicado: (2019)

ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma
por: Zheng, Meng, et al.
Publicado: (2020)

Expression, purification, and characterisation of the p53 binding domain of Retinoblastoma binding protein 6 (RBBP6)
por: Russell, Bonnie L., et al.
Publicado: (2023)

Hypoxia-induced RBBP7 promotes esophagus cancer progression by inducing CDK4 expression: RBBP7 promotes esophagus cancer progression
por: Wang, Renfeng, et al.
Publicado: (2022)

RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression
por: Dlamini, Zodwa, et al.
Publicado: (2019)

Application of the RBBP9 Serine Hydrolase Inhibitor, ML114, Decouples Human Pluripotent Stem Cell Proliferation and Differentiation
por: Lim, Seakcheng, et al.
Publicado: (2020)

Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients
por: Luo, Fan-Yan, et al.
Publicado: (2015)

Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Cheng, Xu, et al.
Publicado: (2021)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer
por: Jiang, Chao, et al.
Publicado: (2018)

Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
por: Cheng, Yuanjun, et al.
Publicado: (2020)

High expression of Stabilin-2 predicts poor prognosis in non-small-cell lung cancer
por: Yong, Juanjuan, et al.
Publicado: (2021)

SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer
por: Wu, Dong-ming, et al.
Publicado: (2017)

Overexpression of lncRNA EGFR AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non small cell lung cancer
por: Xu, Yu-Hua, et al.
Publicado: (2019)

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma
por: Sun, Gaofeng, et al.
Publicado: (2021)

SMOX expression predicts the prognosis of non-small cell lung cancer
por: Huang, Zhanghao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h1s1ni68i8299b5ql8kq6m3ub9